KAT I activators, where KAT I stands for lysine acetyltransferase I, belong to a class of biochemical compounds that specifically enhance the activity of the KAT I enzyme. These molecules operate at a cellular and molecular level to modulate the epigenetic landscape by influencing the acetylation status of histone proteins. The primary function of KAT I is to transfer acetyl groups from acetyl-CoA to lysine residues on histone tails, a process that plays a pivotal role in the regulation of gene expression by altering chromatin structure and dynamics. Activators of KAT I can enhance this acetylation process, leading to a more open chromatin conformation and facilitating the transcriptional machinery's access to DNA.
The chemical structures of KAT I activators are diverse, reflecting the complexity of the enzyme's active site and the intricate nature of its catalytic mechanism. These activators may be designed to interact directly with the enzyme's substrate-binding domain, allosteric sites, or the acetyl-CoA binding region, thereby enhancing its histone acetyltransferase activity. Some activators function by mimicking the natural substrates of the enzyme, effectively increasing the enzyme's affinity for its substrates or altering its conformational state to a more catalytically active form. Other members of this class may bind to regions of the enzyme to stabilize it in an active conformation or prevent its deactivation. Since KAT I is a crucial regulator of gene expression, the precise modulation of its activity through small molecule activators can have significant downstream effects on the expression of genes, impacting various cellular pathways and functions. These activators are valuable tools in research, providing insights into the mechanisms governing gene regulation and the intricate interplay of enzymatic modifications that control chromatin architecture.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor that may indirectly upregulate KAT I by increasing histone acetylation and enhancing transcription of HAT genes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor that could increase KAT I expression by creating a more transcriptionally active chromatin environment. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNMT inhibitor that may promote KAT I expression by reducing methylation levels of the KAT1 gene promoter, thus enhancing transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
DNMT inhibitor that could lead to the demethylation and subsequent transcriptional activation of the KAT1 gene. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator of PKC that might enhance KAT I expression through PKC-mediated signaling pathways leading to increased gene transcription. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
SIRT1 activator and HDAC inhibitor, potentially increasing KAT I expression through epigenetic changes favoring gene activation. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
HDAC inhibitor that may indirectly lead to increased KAT I expression by promoting a more open chromatin structure at the HAT gene loci. | ||||||
Allicin | 539-86-6 | sc-202449 sc-202449A | 1 mg 5 mg | $489.00 $1557.00 | 7 | |
Known for HDAC inhibitory activity, which could indirectly promote KAT I expression by enhancing histone acetylation and gene transcription. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
HDAC inhibitor, possibly enhancing KAT I expression by increasing histone acetylation and favoring transcription of the KAT1 gene. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
HDAC inhibitor that may increase KAT I expression by causing hyperacetylation of histones near the KAT1 gene, facilitating its transcription. | ||||||